ARCA biopharma (NASDAQ:ABIO) reported quarterly losses of $(0.16) per share. This is a 51.52 percent increase over losses of $(0.33) per share from the same period last year.
VodafoneZiggo Extends Multi-Year Managed Services Agreement With Amdocs To Elevate Operational Excellence
Collaboration will strengthen cooperation and commitment to deliver an improved customer experienceJERSEY CITY, NJ / ACCESSWIRE / November 7, 2023 / Amdocs (NASDAQ:DOX), a leading provider of software and services to